A detailed history of Lpl Financial LLC transactions in Atossa Therapeutics, Inc. stock. As of the latest transaction made, Lpl Financial LLC holds 45,406 shares of ATOS stock, worth $48,584. This represents 0.0% of its overall portfolio holdings.

Number of Shares
45,406
Previous 45,517 0.24%
Holding current value
$48,584
Previous $54,000 27.78%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

SELL
$1.09 - $1.52 $120 - $168
-111 Reduced 0.24%
45,406 $69,000
Q2 2024

Aug 07, 2024

SELL
$1.03 - $2.1 $242 - $493
-235 Reduced 0.51%
45,517 $54,000
Q1 2024

May 10, 2024

SELL
$0.8 - $1.89 $992 - $2,343
-1,240 Reduced 2.64%
45,752 $82,000
Q4 2023

Feb 14, 2024

SELL
$0.63 - $0.98 $1,890 - $2,940
-3,000 Reduced 6.0%
46,992 $41,000
Q3 2023

Nov 13, 2023

BUY
$0.74 - $1.35 $2,220 - $4,050
3,000 Added 6.38%
49,992 $36,000
Q2 2023

Jul 31, 2023

BUY
$0.6 - $1.28 $28,195 - $60,149
46,992 New
46,992 $59,000

Others Institutions Holding ATOS

About ATOSSA THERAPEUTICS, INC.


  • Ticker ATOS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 126,624,000
  • Market Cap $135M
  • Description
  • Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of medicines in the areas of oncology and infectious diseases. The company's lead program is Endoxifen, an active metabolite of tamoxifen, which is in Phase II clinical trials to treat and prevent breast cancer. It is also developing A...
More about ATOS
Track This Portfolio

Track Lpl Financial LLC Portfolio

Follow Lpl Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lpl Financial LLC with notifications on news.